JP2005314380A5 - - Google Patents

Download PDF

Info

Publication number
JP2005314380A5
JP2005314380A5 JP2005088634A JP2005088634A JP2005314380A5 JP 2005314380 A5 JP2005314380 A5 JP 2005314380A5 JP 2005088634 A JP2005088634 A JP 2005088634A JP 2005088634 A JP2005088634 A JP 2005088634A JP 2005314380 A5 JP2005314380 A5 JP 2005314380A5
Authority
JP
Japan
Prior art keywords
insulin resistance
agent
improving agent
insulin
diabetes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2005088634A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005314380A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2005088634A priority Critical patent/JP2005314380A/ja
Priority claimed from JP2005088634A external-priority patent/JP2005314380A/ja
Publication of JP2005314380A publication Critical patent/JP2005314380A/ja
Publication of JP2005314380A5 publication Critical patent/JP2005314380A5/ja
Withdrawn legal-status Critical Current

Links

JP2005088634A 2004-03-29 2005-03-25 インスリン抵抗性改善剤を含有する糖尿病治療剤 Withdrawn JP2005314380A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005088634A JP2005314380A (ja) 2004-03-29 2005-03-25 インスリン抵抗性改善剤を含有する糖尿病治療剤

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004094598 2004-03-29
JP2005088634A JP2005314380A (ja) 2004-03-29 2005-03-25 インスリン抵抗性改善剤を含有する糖尿病治療剤

Publications (2)

Publication Number Publication Date
JP2005314380A JP2005314380A (ja) 2005-11-10
JP2005314380A5 true JP2005314380A5 (enExample) 2008-04-24

Family

ID=35442165

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005088634A Withdrawn JP2005314380A (ja) 2004-03-29 2005-03-25 インスリン抵抗性改善剤を含有する糖尿病治療剤

Country Status (1)

Country Link
JP (1) JP2005314380A (enExample)

Similar Documents

Publication Publication Date Title
RU2519660C2 (ru) Режим дозировки селективного агониста рецептора s1p1
TWI455723B (zh) 納曲酮及安非他酮於治療超重或肥胖病患之用途
JP2012520866A5 (enExample)
JP2014528474A5 (enExample)
JP2018507243A5 (enExample)
JP2010540519A5 (enExample)
HK1053058A1 (zh) 普拉克索用於治疗成瘾性疾病的用途
JP2016138142A (ja) 大うつ病を有する患者において減量療法を提供する方法
Park et al. Modified titanium implant as a gateway to the human body: the implant mediated drug delivery system
JP2018509419A5 (enExample)
JP2013536837A5 (enExample)
JP2020536121A5 (enExample)
JP2025072496A (ja) ジスキネジア治療薬
CN101437530A (zh) 一种烟叶提取物及其在依赖治疗中的应用
JP2009506043A5 (enExample)
BR112019026029A2 (pt) Formulações farmacêuticas orais de remogliflozina
JP2012502105A5 (enExample)
JP2005314380A5 (enExample)
JP2006508118A5 (enExample)
JP6454436B1 (ja) ペマフィブラートを含有する医薬
JP2001039976A5 (enExample)
KR20200136008A (ko) 신경퇴행성 장애의 치료를 위한 약제학적 조성물의 연속 투여
JP2009501707A5 (enExample)
WO2016001185A1 (en) Dosage regimen for the treatment of diabetes
JP2020045332A (ja) 慢性便秘症を治療するための医薬組成物